- Written by: (Investorideas.com newswire, breaking stock market
- Fri, 02 Aug 2024
- United States
August 2, 2024 (Investorideas.com Newswire) Investorideas.com, a go-to investing platform covering biotech and nanotechnology issues a snapshot looking at news and developments in the antiviral market, featuring NanoViricides, Inc. (NYSE American: NNVC), a development stage company that is creating special purpose nanomaterials for antiviral therapy.